Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.69 |
| ▸ | NPC1 | O15118 | 7/20 | 0.69 |
| ▸ | RAB9A | P51151 | 7/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.69 |
| ▸ | MAPT | P10636 | 6/20 | 0.69 |
| ▸ | MEN1 | O00255 | 3/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.69 |
| ▸ | GAA | P10253 | 3/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.69 |
| ▸ | ILK | Q13418 | 3/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | GLA | P06280 | 2/20 | 0.55 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 3/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9464517 | 0.88 | KDM4E (0.63) | KDM4ENPC1RAB9AALDH1A1MAPT | |
| SCHEMBL23677964 | 0.88 | KDM4E (0.63) | KDM4ENPC1RAB9AALDH1A1MAPT | |
| SCHEMBL21742670 | 0.86 | RAB9A (0.61) | KDM4ENPC1RAB9AALDH1A1MAPT | |
| SCHEMBL231307 | 0.86 | KDM4E (0.75) | KDM4ENPC1RAB9AALDH1A1MAPT | |
| SCHEMBL10414016 | 0.85 | KDM4E (0.64) | KDM4ENPC1RAB9AALDH1A1MAPT | |
| SCHEMBL7192851 | 0.85 | RAB9A (0.68) | KDM4ENPC1RAB9AALDH1A1MAPT | |
| SCHEMBL12854008 | 0.84 | KDM4E (0.72) | KDM4ENPC1RAB9AALDH1A1MAPT | |
| SCHEMBL2139104 | 0.83 | MAPT (0.57) | KDM4ENPC1RAB9AALDH1A1MAPT | |
| SCHEMBL23176467 | 0.83 | MAPT (0.55) | KDM4ENPC1RAB9AALDH1A1MAPT | |
| SCHEMBL21742669 | 0.82 | RAB9A (0.60) | KDM4ENPC1RAB9AALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4310089-A1 | NITROGEN-CONTAINING HETEROCYCLIC POLYCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | Shanghai Hansoh Biomedical Co., Ltd. (CN) | 2024-01-24 | — | — | EP | disclosed |
| US-20230141905-A1 | LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-11 | — | — | US | disclosed |
| CN-108250157-B | Method for synthesizing N- [2- (2-arylbenzothiazole) ] -amide under catalysis of rhodium | 江西师范大学 | 2021-12-21 | — | — | CN | disclosed |
| CN-110156716-B | Synthetic method of benzothiazole ester derivative | 安徽师范大学 | 2021-08-27 | — | — | CN | disclosed |
| US-20210257564-A1 | IRIDIUM COMPLEX COMPOUND, COMPOSITION CONTAINING THE COMPOUND AND SOLVENT, ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THE COMPOUND, DISPLAY DEVICE, AND ILLUMINATION DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2021-08-19 | — | — | US | disclosed |
| US-11038126-B2 | Iridium complex compound, composition containing the compound and solvent, organic electroluminescent element containing the compound, display device, and illumination device | MITSUBISHI CHEMICAL CORPORATION (JP) | 2021-06-15 | — | — | US | disclosed |
| EP-3164898-B1 | ORGANIC LIGHT-EMITTING DIODE (OLED) INCLUDING AN ELECTRON TRANSPORT LAYER STACK COMPRISING DIFFERENT LITHIUM COMPOUNDS | NOVALED GMBH (DE) | 2021-05-12 | — | — | EP | disclosed |
| US-20200274078-A1 | IRIDIUM COMPLEX COMPOUND, COMPOSITION CONTAINING THE COMPOUND AND SOLVENT, ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THE COMPOUND, DISPLAY DEVICE, AND ILLUMINATION DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-08-27 | — | — | US | disclosed |
| EP-3637489-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | Samsung Electronics Co., Ltd. (KR) | 2020-04-15 | — | — | EP | disclosed |
| CN-110156716-A | A kind of synthetic method of benzothiazole ester derivative | 安徽师范大学 | 2019-08-23 | — | — | CN | disclosed |
| US-20090114355-A1 | ORGANIC FLUORESCENT COMPOSITIONS | HONEYWELL INTERNATIONAL INC. (US) | 2009-05-07 | — | — | US | disclosed |
| EP-1300396-B1 | 1,2-DIHYDROPYRIDINE COMPOUNDS, PROCESS FOR PREPARATION OF THE SAME AND USE THEREOF | EISAI R&D MAN CO LTD (JP) | 2009-01-14 | — | — | EP | disclosed |
| EP-1465626-B1 | PHARMACEUTICAL COMPOSITIONS (KIT) COMPRISING DIHYDROPYRIDINONE COMPOUNDS AND AN IMMUNOREGULATORY (OR AN ANTIINFLAMMATORY) AGENT AND THEIR USES | EISAI R&D MAN CO LTD (JP) | 2008-09-03 | — | — | EP | disclosed |
| US-7262212-B2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-08-28 | — | — | US | disclosed |
| US-7262212-B2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-08-28 | — | — | US | disclosed |
| US-20050096471-A1 | Process for producing biaryl compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-05-05 | — | — | US | disclosed |
| EP-1473286-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2004-11-03 | — | — | EP | disclosed |
| WO-2003047577-A2 | PHARMACEUTICAL COMPOSITIONS COMPRISING DIHYDROPYRIDINONE COMPOUNDS AND AN IMMUNOREGULATORY OR AN ANTIINFLAMMATORY AGENT AND THEIR USES | EISAI CO LTD (JP) | 2003-06-12 | — | — | WO | disclosed |
| US-3962056-A | MOLDING, COATING | EASTMAN KODAK COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
| US-3962055-A | MOLDING, COATING | EASTMAN KODAK COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210257564-A1 | IRIDIUM COMPLEX COMPOUND, COMPOSITION CONTAINING THE COMPOUND AND SOLVENT, ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THE COMPOUND, DISPLAY DEVICE, AND ILLUMINATION DEVICE | RB1, ARL1, CDKL1 | KDM4E 2827/4885NPC1 4417/4885RAB9A 870/4885 |
| US-20090114355-A1 | ORGANIC FLUORESCENT COMPOSITIONS | PFAS, FUS, ACR | KDM4E 3212/4885NPC1 425/4885RAB9A 2507/4885 |
| US-11038126-B2 | Iridium complex compound, composition containing the compound and solvent, organic electroluminescent element containing the compound, display device, and illumination device | ACVRL1, CCNL2, CXCR1 | KDM4E 4283/4885NPC1 4637/4885RAB9A 3252/4885 |
| US-20050096471-A1 | Process for producing biaryl compound | PPOX, CAT, TYR | KDM4E 3428/4885NPC1 4102/4885RAB9A 2254/4885 |
| US-20200274078-A1 | IRIDIUM COMPLEX COMPOUND, COMPOSITION CONTAINING THE COMPOUND AND SOLVENT, ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THE COMPOUND, DISPLAY DEVICE, AND ILLUMINATION DEVICE | ACVRL1, CCNL2, CXCR1 | KDM4E 4283/4885NPC1 4637/4885RAB9A 3252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.